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Paediatric living donor liver transplantation
J F Botha
Liver transplantation (LT) is the definitive treatment for children 
with end-stage liver disease (ESLD). The greatest limitation for LT 
is scarcity of deceased donor organs. This is particularly critical for 
smaller children (weighing <10 kg). Living donor liver transplantation 
(LDLT) has emerged over the last 2 decades as a viable alternative 
option, offering children definitive treatment, reducing their mortality 
while on the waiting list, and providing adequate long-term graft and 
patient survival.1 Compared with the whole-size deceased donor graft, 
LDLT in children presents a greater technical challenge with a greater 
chance of complications. The shorter vascular pedicles, the orientation 
and the size mismatch between the vessels of graft and recipient 
can lead to multiple forms of vascular complications. Graft size can 
increase the technical challenge and even compromise abdominal wall 
closure. The presence of a cut surface can lead to bleeding and/or bile 
leakage, and the size of the bile duct along with its blood supply can 
compromise adequate biliary drainage. Here I comprehensively review 
paediatric LDLT and its most recent developments.
Indications
Indications for LT in children include: 
• extrahepatic cholestasis, e.g. biliary atresia
• intrahepatic cholestasis, e.g. Alagille syndrome, and progressive 
familial intrahepatic cholestasis (PFIC) syndromes
• metabolic diseases such as Wilson’s disease, alpha 1 antitrypsin 
deficiency, Crigler-Najjar syndrome, and other inborn errors of 
metabolism (tyrosinaemia, hyperoxaluria, organic acidaemias)
• fulminant hepatic failure
• primary liver tumours, e.g. hepatoblastoma and hepatocellular 
carcinoma (HCC).
Cholestatic liver diseases
Biliary atresia is the most common indication for LT in children. 
Typically, most of these children will have undergone a Kasai’s 
procedure that has failed to establish bile flow, and transplantation is 
necessitated by the development of secondary biliary cirrhosis. 
Metabolic diseases
The group of metabolic diseases accounts for the second most 
common indication for LT. The metabolic diseases are divided into 
those associated with structural damage to the liver (Wilson’s, alpha-
1 antitrypsin) and those in which the liver is structurally normal 
and LT is required to replace a life-threatening enzyme deficiency 
(Crigler-Najjar syndrome, ornithine transcarbamylase deficiency, or 
hyperoxaluria type 1).
Liver tumours
Non-resectable hepatoblastoma is effectively treated with total 
hepatectomy and transplantation. HCC is often secondary to other 
metabolic conditions (e.g. tyrosinaemia) and, if contained within 
the liver, is also effectively treated with total hepatectomy and 
transplantation.2
Surgery
Thomas Starzl performed the first human LT in a 2-year-old child 
with biliary atresia 4 decades ago.3 The patient died in the operating 
room of uncontrolled haemorrhaging. The evolution of paediatric 
LT has focused mainly on the refinement of its surgical techniques 
to counteract the critical shortage of deceased donor organs. This 
shortage is most profound for children, who require smaller grafts. 
Given the low number of paediatric donors, up to 50% of children 
would die while on the waiting list before receiving a transplant. To 
alleviate the lack of available organs for young recipients, reduced and 
then split deceased LTs were performed in the 1980s. The development 
of these techniques has almost eliminated waiting list mortality for 
children.4 The scarcity of organs has been alleviated also in part by 
the development of LDLT programmes in various centres worldwide. 
Eighty per cent of the paediatric deaths caused by liver disease occur in 
children aged <2 years. LDLT offers several advantages over deceased 
donation, including: reduced time on the waiting list; procurement 
under optimal conditions from a healthy donor; a shorter cold 
ischaemia time; and elective scheduling of the operation.
Donor selection
The typical living donor is a parent or first-degree relative of compatible 
bloodtype and aged between 18 and 55 years. The donor undergoes 
thorough medical and psychological evaluation, after which detailed 
imaging (computed tomography or magnetic resonance imaging) is 
performed to evaluate the potential graft size, as well as vascular and 
biliary anatomy. In general, children are well served by receiving a left 
lateral segment graft. Donor safety is the over-riding concern and has 
been excellent after left lateral segmentectomy, with a usually quoted 
donor mortality of 0.02 -   0.05% (a risk approaching that of donating 
a kidney).5
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Paediatric liver transplantation is a highly effective therapy for 
children with end-stage liver disease; 1-year survival rates currently 
exceed 90% and long-term survivors enjoy an almost-normal 
quality of life. Key to the success of paediatric liver transplantation 
has been the technical refinement to provide children with suitably 
sized grafts. Adult-to-paediatric living donor liver transplantation 
highlights this success and has been instrumental in decreasing 
waiting list mortality to less than 5%.
S Afr Med J 2012;102(11):879-880. DOI:10.7196/SAMJ.6261
FORUM
880  November 2012, Vol. 102, No. 11  SAMJ
The first LDLT, in which segments 2 and 3 were procured from 
the mother and transplanted into a child with biliary atresia, was 
reported in 1988.6 The procurement usually involves removing the 
left lateral segment along with the left branch of the portal vein, left 
hepatic artery and left hepatic vein. The recipient operation is similar 
to that of implantation of a cadaveric split left graft; the inferior vena 
cava (IVC) is preserved, the left hepatic vein is anastomosed to the 
recipient IVC, and the left portal vein of the graft is anastomosed 
to the main portal vein in the recipient. The arterial anastomosis is 
slightly more difficult as only the left hepatic artery is available; this 
is usually anastomosed to the recipient common hepatic artery. The 
biliary anastomosis is technically difficult because it is performed 
at the level of the right or left hepatic duct. Biliary reconstruction 
is more commonly in the form of a Roux-en-Y, due to the size 
mismatch and the anatomical position and orientation conferred by 
the size of the graft.
Biliary atresia leading to cirrhosis is by far the most common cause 
of ESLD in the paediatric population, accounting for over 50% of 
the indications for LT.7 The portal vein in this subset of patients is 
typically hypo-plastic and narrow, as a result of recurrent cholangitis 
and previous Kasai’s portoenterostomy. This usually means that the 
portal vein needs to be dissected back to the splenoportal junction 
and may require the use of vein grafts.8 The artery, however, is usually 
unexpectedly larger for the size of the child, making the arterial 
anastomosis relatively straightforward. Because children with biliary 
atresia have usually had prior abdominal surgery, operative blood 
loss and the risk of enterotomies are higher. Furthermore, there may 
be associated cardiac and intestinal anomalies that need to be known 
prior to transplantation so that the best post-operative care can be 
rendered.9
LDLT for the paediatric recipient, especially in smaller children, 
has led to the development of new surgical techniques to increase 
the donor pool. Almost all of these techniques use the left lateral 
segment (segments 2 and 3) for transplantation, but even this graft 
could be too large for children weighing <10 kg. Monosegment LT 
appears to be a satisfactory option for infants weighing <10 kg. Either 
segment 2 or 3 can be transplanted with satisfactory results in very 
small children.10
LDLT has been widely debated from a societal and ethical point of 
view and has become an accepted procedure worldwide, especially 
for paediatric recipients.11,12 Donor mortality and morbidity rates are 
low following left lateral segment donation, and recipient survival 
rates are between 80% and 90% at 1 year post-transplantation in 
experienced centres.13
Post-operative complications
Primary non-functioning of the liver following transplantation, 
although rare, is a devastating complication and needs to be recognised 
early to allow appropriate management and re-transplantation to be 
offered. Similarly, hepatic artery thrombosis usually also leads to 
massive hepatic necrosis and allograft failure also necessitating 
retransplantation.14 If identified early, arterial reconstruction can be 
attempted with variable results. Portal vein thrombosis usually does 
not result in graft loss, but needs to be corrected by thrombectomy 
and anastomotic revision when detected in the early post-transplant 
period.15 Left lateral segment grafts in particular are associated with 
an increased risk of problems with the hepatic venous anastomosis, 
and can sometimes result in acute Budd-Chiari syndrome; these may 
be avoided by attention to technique. 
Biliary complications occur in 10 - 20% of paediatric LDLT 
recipients; bile leaks from the cut surface of the liver or the 
anastomosis are the most common. Drainage is usually required.
Cut surface leaks are mostly self-limiting and can be managed 
conservatively while anastomotic leaks may require re-operation and 
anastomotic revision. Later on, anastomotic strictures can occur and 
are usually managed by percutaneous means and occasionally by 
revision of the anastomosis.
Conclusion
LDLT has been widely debated from a societal and ethical context, 
and has become an accepted procedure worldwide, especially for 
paediatric recipients. Donor mortality and morbidity rates are 
low following left lateral segment donation, and recipient survival 
rates are between 80% and 90% at 1 year post transplantation in 
experienced centres. The good survival rates following LDLT allow 
transplantation to take place before the onset of life-threatening 
complications and severe nutritional failure.
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